Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 4

The DOI matches its Crossref record; the references it cites are not checked yet.

Evaluation of the efficacy and safety of topical procyanidin b2 and placebo in the treatment of androgenetic alopecia in men; A randomized, double-blind, placebo-controlled study

Yeniay, Yıldıray, Arca, Ercan·2022·Turkish Journal of Dermatology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/tjd.tjd_41_22

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

Cited by 4

Research works printed but not linked: 33

  1. Arca E, Açikgöz G, Taştan HB, Köse O, Kurumlu Z An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Dermatology 2004;209:117-25. · doi:10.1159/000079595
  2. Tosti A, Piraccini BM Androgenetic alopecia. International Journal of Dermatology 1999;38 Suppl 1:1-7. PubMed PMID: 10369534. · doi:10.1046/j.1365-4362.1999.00002.x
  3. Trüeb RM Molecular mechanisms of androgenetic alopecia. Exp Gerontol 2002;37:981-90. · DOI · Paper page
  4. Srogi K Mercury content of hair in different populations relative to fish consumption. Rev Environ Contam Toxicol 2007;189:107-30. · DOI
  5. Fischer TW, Trüeb RM, Hänggi G, Innocenti M, Elsner P Topical melatonin for treatment of androgenetic alopecia. Int J Trichology 2012;4:236-45. · DOI
  6. Su LH, Chen TH Association of androgenetic alopecia with metabolic syndrome in men: A community-based survey. Br J Dermatol 2010;163:371-7. · DOI
  7. Lu, 2009, Profiling the response of human hair follicles to ultraviolet radiation, J Invest Dermatol, 1790, 10.1038/jid.2008.418 · DOI
  8. Mahé, 2000, Androgenetic alopecia and microinflammation, Int J Dermatol, 576, 10.1046/j.1365-4362.2000.00612.x · DOI · Paper page
  9. Hernandez BA Is androgenic alopecia a result of endocrine effects on the vasculature? Med Hypotheses 2004;62:438-41. · doi:10.1016/s0306-9877(03)00342-6
  10. Gupta AK, Mays RR, Versteeg SG, Shear NH, Piguet V, Piraccini BM Efficacy of off-label topical treatments for the management of androgenetic alopecia: A review. Clin Drug Investig 2019;39:233-9. · doi:10.1007/s40261-018-00743-8
  11. Takahashi T, Kamimura A, Kagoura M, Toyoda M, Morohashi M Investigation of the topical application of procyanidin oligomers from apples to identify their potential use as a hair-growing agent. J Cosmet Dermatol 2005;4:245-9. · DOI
  12. Kamimura A, Takahashi T, Watanabe Y Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent. Phytomedicine 2000;7:529-36. · DOI
  13. Nestor MS, Ablon G, Gade A, Han H, Fischer DL Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol 2021;20:3759-81. · DOI · Paper page
  14. Shin, 2007, 01% tretinoin for male pattern hair loss: A randomized, double-blind, comparative clinical trial, Am J Clin Dermatol, 285, 10.2165/00128071-200708050-00003 · doi:10.2165/00128071-200708050-00003
  15. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology 2002;47:377-85. Epub 2002/08/28. PubMed PMID: 12196747. · DOI · Paper page
  16. Blume-Peytavi, 2019, Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study, J Cosmet Dermatol, 215, 10.1111/jocd.12541 · doi:10.1111/jocd.12541
  17. Whitmore SE The importance of proper vehicle selection in the detection of minoxidil sensitivity. Arch Dermatol 1992;128:653-6. · doi:10.1001/archderm.128.5.653
  18. Satoh H, Morikaw S, Fujiwara C, Terada H, Uehara A, Ohno R A case of acute myocardial infarction associated with topical use of minoxidil (riup) for treatment of baldness. Jpn Heart J 2000;41:519-23. · DOI
  19. Gupta AK, Charrette A The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: A network meta-analysis and benefit-risk assessment of finasteride and dutasteride. J Dermatolog Treat 2013;25:156-61. · DOI
  20. Van, 2000, Finasteride increases anagen hair in men with androgenetic alopecia, Br J Dermatol, 804
  21. Finasteride, 2002, Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia, Eur J Dermatol, 38
  22. Irwig MS, Kolukula S Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med 2011;8:1747-53. · DOI · Paper page
  23. Kamimura A, Takahashi T, Morohashi M, Takano Y Procyanidin oligomers counteract Tgf-beta1- and Tgf-beta2-induced apoptosis in hair epithelial cells: An insight into their mechanisms. Skin Pharmacol Physiol 2006;19:259-65. · DOI
  24. Takahashi T, Kamiya T, Hasegawa A, Yokoo Y Procyanidin oligomers selectively and intensively promote proliferation of mouse hair epithelial cells in vitro and activate hair follicle growth in vivo. J Invest Dermatol 1999;112:310-6. · DOI
  25. Danilenko DM, Ring BD, Pierce GF Growth factors and cytokines in hair follicle development and cycling: Recent insights from animal models and the potentials for clinical therapy. Mol Med Today 1996;2:460-7. · DOI
  26. Benassi, 1997, 1,25-dihydroxyvitamin D3, transforming growth factor beta1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes, J Invest Dermatol, 276, 10.1111/1523-1747.ep12335756 · DOI
  27. Hibino T, Nishiyama T Role of Tgf-beta2 in the human hair cycle. J Dermatol Sci 2004;35:9-18. · DOI · Paper page
  28. Kamimura A, Takahashi T Procyanidin B-2, extracted from apples, promotes hair growth: A laboratory study. Br J Dermatol 2002;146:41-51. · DOI
  29. El-Esawy FM, Hussein MS, Ibrahim Mansour A Serum biotin and zinc in male androgenetic alopecia. J Cosmet Dermatol 2019;18:1546-9. · doi:10.1111/jocd.12865
  30. Kutlu Ö Dexpanthenol may be a novel treatment for male androgenetic alopecia: Analysis of nine cases. Dermatol Ther 2020;33:e13381. Epub 2020/04/08. doi: 10.1111/dth.13381. PubMed PMID: 32255530. · doi:10.1111/dth.13381
  31. Takahashi T, Kamimura A, Yokoo Y, Honda S, Watanabe Y The first clinical trial of topical application of procyanidin B-2 to investigate its potential as a hair growing agent. Phytother Res 2001;15:331-6. · doi:10.1002/ptr.800
  32. Kreindler TG Topical minoxidil in early androgenetic alopecia. J Am Acad Dermatol 1987;16:718-24. · DOI
  33. Kaufman, 1998, Finasteride in the treatment of men with androgenetic alopecia.Finasteride male pattern hair loss study group, J Am Acad Dermatol, 578, 10.1016/S0190-9622(98)70007-6 · DOI · Paper page

Metadata

Authors
Yeniay, Y., & Arca, E.
Venue
Turkish Journal of Dermatology
Published
2022
Volume
16
Issue
4
Pages
108
ISSN
1307-7635
Cited by
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of the efficacy and safety of topical procyanidin b2 and placebo in the treatment of androgenetic alopecia in men; A randomized, double-blind, placebo-controlled study. https://app.cochat.ai/papers/10.4103/tjd.tjd_41_22
The paper
Yeniay, Y., & Arca, E. (2022). Evaluation of the efficacy and safety of topical procyanidin b2 and placebo in the treatment of androgenetic alopecia in men; A randomized, double-blind, placebo-controlled study. Turkish Journal of Dermatology. https://doi.org/10.4103/tjd.tjd_41_22

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.